Location History:
- Flüh, CH (2013)
- Fluh, CH (2015)
Company Filing History:
Years Active: 2013-2015
Title: Cees Winninps: Innovator in Pharmaceutical Purity
Introduction
Cees Winninps is a notable inventor based in Fluh, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of drug purity. With a total of two patents to his name, Winninps has focused on enhancing the quality and stability of important pharmaceutical compounds.
Latest Patents
Winninps' latest patents revolve around highly pure pentamycin. He has described pentamycin in a purity exceeding 95%, along with certain polymorphs and solvates of the compound. His patents also detail processes for the manufacture of these forms and a method for decreasing the rate of degradation of pentamycin. This work is crucial for ensuring the efficacy and safety of the drug in medical applications.
Career Highlights
Cees Winninps is associated with Biolotus Biotechnology AG, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of pentamycin, a vital antibiotic.
Collaborations
Winninps collaborates with notable colleagues such as Karl Reuter and Florian Stolz. Their combined expertise contributes to the ongoing research and development efforts at Biolotus Biotechnology AG.
Conclusion
Cees Winninps stands out as an influential inventor in the pharmaceutical industry, particularly through his work on pentamycin. His contributions are vital for improving drug purity and stability, which ultimately benefits healthcare outcomes.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.